In the 3rd study measuring low-dose (1 μg) cosyntropin-stimulated peak serum cortisol, after 12 weeks of treatment, there was no significant difference in the mean change from baseline versus placebo for either CIC320 (P=0.383) or CIC640 (P=0.911).